⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1054734 | 1.00 | — | — | |
| SCHEMBL883229 | 1.00 | — | — | |
| SCHEMBL1080236 | 0.98 | SLC1A2 (0.43) | — | |
| SCHEMBL20040262 | 0.87 | EPHX1 (0.47) | — | |
| SCHEMBL15173701 | 0.87 | EPHX1 (0.47) | — | |
| SCHEMBL15173700 | 0.87 | EPHX1 (0.47) | — | |
| SCHEMBL4588183 | 0.79 | — | — | |
| SCHEMBL18771244 | 0.79 | — | — | |
| SCHEMBL21728725 | 0.79 | — | — | |
| SCHEMBL312743 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022115477-A1 | BCL-XL INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF | NOVARTIS AG (CH) | 2022-06-02 | — | — | WO | disclosed |
| CN-108289893-B | Human plasma kallikrein inhibitors | 拜奥克里斯特制药公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-102459165-B | Antiviral compound | ABBVIE (US) | 2015-09-02 | — | — | CN | disclosed |
| CN-102459165-A | Anti-viral compounds | ABBOTT LAB | 2012-05-16 | — | — | CN | disclosed |
| EP-2448946-A1 | 2-CARBOXAMIDE CYCLOAMINO UREAS USEFUL AS PI3K INHIBITORS | Novartis AG (CH) | 2012-05-09 | — | — | EP | disclosed |
| WO-2011000855-A1 | 2-CARBOXAMIDE CYCLOAMINO UREAS USEFUL AS PI3K INHIBITORS | NOVARTIS AG (CH) | 2011-01-06 | — | — | WO | disclosed |